Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical hyperbaric therapy for problem skin wounds

M C Heng1

  • 1Department of Medicine, UCLA San Fernando Valley Internal Medicine Program, Veterans Administration Medical Center, Sepulveda.

The Journal of Dermatologic Surgery and Oncology
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiogenesis in necrotic ulcers treated with hyperbaric oxygen.

Ostomy/wound management·2001
Same author

Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters.

The British journal of dermatology·2000
Same author

Involvement of luminal bacteria, heat shock protein 60, macrophages and gammadelta T cells in dextran sulfate sodium-induced colitis in rats.

Digestive diseases and sciences·2000
Same author

Enhanced healing and cost-effectiveness of low-pressure oxygen therapy in healing necrotic wounds: a feasibility study of technology transfer.

Ostomy/wound management·2000
Same author

Metabolic alterations of zinc and prostaglandins in both human and animal colonic tumor cells.

Journal of the American College of Nutrition·1995
Same author

Heat-shock protein 65 and activated gamma/delta T cells in injured arteries.

Lancet (London, England)·1994
Same journal

Malignant fibrous histiocytoma at the site of total knee replacement.

The Journal of dermatologic surgery and oncology·1994
Same journal

Basal cell carcinoma arising in a surgical scar: reconstructive surgical treatment.

The Journal of dermatologic surgery and oncology·1994
Same journal

The use of hyaluronidase as an adjunct to surgical procedures.

The Journal of dermatologic surgery and oncology·1994
Same journal

Repair of the soft triangle of the nose.

The Journal of dermatologic surgery and oncology·1994
Same journal

Eccrine angiomatous hamartoma.

The Journal of dermatologic surgery and oncology·1994
Same journal

Treatment of pyoderma gangrenosum with cultured keratinocyte autografts.

The Journal of dermatologic surgery and oncology·1994
See all related articles

Topical hyperbaric oxygen therapy offers a safe and effective treatment for open wounds by promoting new blood vessel growth without systemic toxicity. This approach is cost-effective and can be used early in treatment for recalcitrant wounds.

Area of Science:

  • Wound healing research
  • Hyperbaric medicine
  • Vascular biology

Background:

  • Systemic hyperbaric oxygen therapy (HBOT) is the only known treatment to stimulate new blood vessel growth.
  • However, systemic HBOT carries risks of central nervous system and pulmonary toxicity.

Purpose of the Study:

  • To detail topical hyperbaric oxygen therapy (THOT) for treating difficult-to-heal open wounds.
  • To contrast THOT with systemic HBOT.

Main Methods:

  • Description and comparison of topical and systemic hyperbaric oxygen treatments.
  • Outline of the applications of topical hyperbaric oxygen therapy.

Main Results:

  • Topical hyperbaric oxygen therapy is specifically indicated for open wounds.

Related Experiment Videos

  • THOT demonstrates effectiveness in promoting wound healing.

    • Conclusions:

    • Topical hyperbaric oxygen therapy is a cost-effective treatment with no systemic oxygen toxicity.
    • Its effectiveness allows for early application in managing recalcitrant open wounds, unlike systemic HBOT.